Transitions in cell states are controlled by combinatorial actions of transcription factors. BLIMP1, the key regulator of primordial germ cell (PGC) specification, apparently acts together with PRDM14 and AP2γ. To investigate their individual and combinatorial functions, we first sought an in vitro system for transcriptional readouts and chromatin immunoprecipitation sequencing analysis. We then integrated this data with information from single-cell transcriptome analysis of normal and mutant PGCs. Here we show that BLIMP1 binds directly to repress somatic and cell proliferation genes. It also directly induces AP2γ, which together with PRDM14 initiates the PGC-specific fate. We determined the occupancy of critical genes by AP2γ-which, when computed altogether with those of BLIMP1 and PRDM14 (both individually and cooperatively), reveals a tripartite mutually interdependent transcriptional network for PGCs. We also demonstrate that, in principle, BLIMP1, AP2γ and PRDM14 are sufficient for PGC specification, and the unprecedented resetting of the epigenome towards a basal state.
PGCs in mice originate from the rapidly dividing post implantation epiblast cells that are primed for somatic fate, following repression of some pluripotency genes 1 . They also exhibit an inactive X chromosome, histone H3 Lys 9 dimethylation (H3K9me2) and DNA methylation 2, 3 . A transcriptional network for PGC specification should reverse this trend by the time 30-40 founder PGCs are established at embryonic day 7.5 (E7.5).
PGC fate is initiated by BMP4-induced expression of BLIMP1 in a few proximal epiblast cells at E6. 25 (refs 4-8) , which marks their divergence from somatic neighbours (see Fig. 3b ). Indeed, BLIMP1 mutant cells fail as PGCs and resemble neighbouring somatic cells 7, [9] [10] [11] . BLIMP1 binds to a specific DNA sequence [12] [13] [14] [15] [16] [17] [18] [19] [20] to either repress [21] [22] [23] [24] [25] or activate 26 its direct targets. Shortly after BLIMP1, there is induction of Prdm14 also by BMP4 (ref. 6 ), followed by Tcfap2c encoding AP2γ (ref. 27) . Genetic experiments indicate that these factors are individually critical for PGC specification. It is important however to establish whether their combinatorial roles and precise targets are necessary and sufficient for PGC specification, and for the initiation of the unique epigenetic program 28 . In this study we combined information from different experimental models to establish how BLIMP1, PRDM14 and AP2γ contribute to
A R T I C L E S
Relative levels (normalized to Ppia) originate from E7.5 epiblasts 29 , and share important properties of post implantation epiblasts, the precursors of PGCs in vivo 30, 31 .
Repression of somatic program and induction of PGC genes in P19EC cells
We examined P19EC cells for transcriptional response following ectopic expression of BLIMP1-EGFP fusion protein or EGFP alone after 24 h with low (24 h-LO) and high expression (24 h-HI), and all fluorescent cells at 48 h ( Supplementary Fig. S1a ). Whereas the 24 h-HI cells showed an apoptosis response due to a strong dose-dependent effect 24 , this was not the case with 24 h-LO cells. We therefore focused mainly on 24 h-LO and 48 h cells (Supplementary Figs S1b,S2).
BLIMP1 in P19EC cells induced the repression of genes including the mesendodermal factor Eomes, HoxA5, Evx1, Myc and the de novo DNA methyltransferase Dnmt3b ( Supplementary Fig. S1b ), which are amongst the key responses observed in PGCs 2, 32 . Importantly, the PGC genes Nanos3 and Rhox9 were induced. By lowering the statistical threshold to a false discovery rate (FDR) ≤0.05, we detected an induction of Dppa3-Stella and Tcfap2c (encoding AP2γ; Supplementary Fig. S1b and Table S1 ). Furthermore, quantitative PCR with reverse transcription (RT-qPCR) revealed an induction of Dnd1 and Prdm14 at 48 h, and PGC markers, Dazl and Ddx4 (Fig. 1b) . Whereas Oct4-Pou5f1 expression continued (Supplementary  Table S1 ), we noted repression of Nanog, which could explain the induction of Gata4 and FoxQ1 (ref. 33 ; Supplementary  Fig. S1b and Table S1 ). Overall, and in important respects, the response of P19EC to BLIMP1 approximates that seen during PGC specification in vivo. We then examined the effects of all three factors in P19EC cells following stable expression of PRDM14 and AP2γ, both individually and together. We transfected control cells and the stable lines with BLIMP1-EGFP or EGFP alone for 24 h and examined sorted fluorescent cells. This showed repression of Eomes and T-Brachyury, whereas PRDM14 alone suppressed Dnmt3b (Fig. 1c) , its direct target 34 . Whereas BLIMP1 repressed Myc, PRDM14 in combination with AP2γ modestly induced Myc expression, an effect that was overcome by BLIMP1 expression. Thus, repression of somatic regulators is complex, and may not be attributable to BLIMP1 alone.
B r a c h P r o x B r a c h D i s t T a f 3 E h m t 1 T a f 7
The induction of PGC genes revealed cooperative effects of AP2γ and PRDM14, which induced Nanos3 and Prdm1 (encoding BLIMP1), with a modest induction of Ddx4. Whereas Nanos3 induction was attenuated by BLIMP1, Dnd1 was induced by 15-fold when all three factors were present, but Dppa3 was strictly PRDM14 dependent (Fig. 1c) . These observations show that PRDM14 and AP2γ cooperatively induce the germ cell program, with the additional effect of BLIMP1 on Dnd1 induction.
The analysis of P19ECs shows a response to BLIMP1, PRDM14 and AP2γ individually and collectively, with features that are pertinent to PGCs, including the repression of somatic genes and induction of PGC genes. We posit that P19EC cells are appropriate for the identification of direct targets of the three key determinants of PGC specification. (Fig. 2a) . We observed a peak distribution with a median position of +171.5 base pairs (bp) relative to transcriptional start sites (TSSs; Fig. 2b ,c) consistent with BLIMP1 binding on promoters and an enrichment of the previously characterized consensus binding sequence for BLIMP1 (ref. 35 ; P = 1.1 × 10 −388 ; Fig. 2d ). Notably, BLIMP1 bound to T-Brachyury, Eomes and the entire Hox gene loci ( Fig. 2e and Table S3 ) reflecting its role in PGC specification in vivo 7, 9 . Functional category analysis revealed a striking enrichment of BLIMP1 binding to genes encoding transcriptional regulators and of genes regulating developmental processes (Fig. 2f) . Moreover, BLIMP1 was bound to Tcfap2c (encoding AP2γ), which is induced in PGCs (see later).
We validated Myc and several of the BLIMP1-bound regions identified by ChIP-qPCR in P19ECs (Fig. 2g) . We also validated BLIMP1 binding to Eomes, Dnmt3b, HoxB2 and Myc in PGCLCs generated in vitro 36 with a ChIP-grade BLIMP1 antibody 35 ( Fig. 2h ), but comprehensive analysis in PGCLCs was technically not feasible owing to limited amounts of precipitated DNA that could be generated.
To determine the significance of BLIMP1 targets, we scrutinized transcriptional changes in wild-type and Prdm1 (BLIMP1) mutant PGCs from E6.25-E8.5 embryos, including E7.5 somatic neighbours, which share a common ancestry (Fig. 3a) . For this, we performed single-cell RNA-seq analysis and found that all three factors, Prdm1 (encoding BLIMP1), Tcfap2c (encoding AP2γ) and Prdm14, were fully induced by E6.5 in putative PGCs, with extensive repression of somatic and cell-cycle regulators, and induction of the PGC program 2, 7 ( Fig. 3b,c and Supplementary Fig. S3a ,b, Table S4 ). In contrast, we detected expression of somatic genes and a lack of expression of some germ cell genes in Prdm1 mutant cells (Fig. 3b,c) . Overall, the E7.5 single-cell expression profiles of Prdm1 mutant cells clustered with E7.5 somatic cells and not with PGCs (Fig. 3a) .
We then carried out a global assessment of BLIMP1-bound genes in relation to the differentially expressed genes in PGCs (compared with the binding to the whole set of expressed genes). Indeed, BLIMP1 was bound to both repressed (Brachyury and Dnmt3b), and induced (Cbx7 ) genes. Notably, BLIMP1 bound to Tcfap2c (encoding AP2γ), which is induced (Fig. 3c,d and see below) . We calculated the binding scores for reads both inside and outside peak regions and their distance to promoters (see Methods), as well as the defined peak regions. This revealed that the repressed genes in E7.5-E8.5 PGCs, compared with either somatic cells or Prdm1 (BLIMP1) mutant cells, are enriched for BLIMP1 (Fig. 4a) . The repressed genes that were bound by BLIMP1 had a greater enrichment for developmental, transcriptional and Wnt-signalling function when compared with the whole set of repressed genes ( Supplementary Fig. S3a ). As misregulated gene expression in the Prdm1 mutant cells from in vivo is a direct consequence of the lack of BLIMP1 in these cells, this result further shows the functional relevance of our analysis to the processes occurring during PGC specification in vivo.
Comparing the ChIP-seq data with the BLIMP1-induced changes in P19ECs revealed a predominant effect on repression of direct targets. Whereas BLIMP1 bound with 24.1% of the genes in the genome (Fig. 4b , Whole Array), nearly 50% of the repressed genes were bound by BLIMP1, but binding to induced genes was close to background ( Fig. 4b) . We further observed a striking enrichment of BLIMP1 binding on repressed genes in both P19ECs as well as in E7.5 PGCs when compared with soma ( Fig. 4c and Supplementary Fig. S3e ) where 34/59 repressed genes were bound by BLIMP1. This is statistically a very high over-representation, (χ 2 P-value = 1.8×10 −10 ), which shows conclusively that the dominant effect of BLIMP1 in PGC specification is gene repression, including those required for the somatic fate. 
AP2γ binds to germ cell genes and somatic regulators
Towards building a genetic network for PGC specification, we performed an unbiased scan of the BLIMP1-binding regions for transcription factor binding motifs ( Supplementary Fig. S4a ). We found a bimodal distribution of AP2 family motifs surrounding the BLIMP1 peak ( Supplementary Fig. S4b ). Similarly, PRDM14-binding sites were also highly enriched for AP2 motifs 34 ( Supplementary  Fig. S4c,d ). We therefore mapped PRDM14-and BLIMP1-binding sites to all of the genes in the PGC transcriptome, and then found AP2γ motifs within the binding regions [37] [38] [39] . This revealed a preferential enrichment of genes regulated during PGC specification that were associated with BLIMP1-and PRDM14-binding sites that contained AP2γ motifs ( Supplementary Fig. S4e ). This strongly implies that the three factors cooperate both in gene induction and repression in PGCs. This prompted us to carry out ChIP-seq analysis for AP2γ.
With P19ECs stably expressing AP2γ, we performed ChIP-seq with a previously validated antibody 39 , and identified 3,191 high-confidence AP2γ-binding regions that map to 1,393 genes (Supplementary  Tables S5 and S6 ). The peaks were enriched with the AP2 consensus motif ( Fig. 5a ) (P = 1.1 × 10 241 ). AP2γ binding was centred on promoters at a median position of − 53 bp relative to the TSS, albeit the peak distribution was much broader than that of BLIMP1 ( Fig. 5b) , perhaps implying binding to gene-distal sequence elements. Importantly, the Pou5f1 distal enhancer, which is bound by PRDM14 and pluripotency transcription factors, was amongst the most strongly bound regions 34, 40, 41 ( Fig. 5c) . Notably, Pou5f1 expression in the post implantation epiblast and P19ECs is driven from the proximal enhancer, whereas the distal enhancer is used following PGC specification. Several somatic genes were also bound by AP2γ, including Hoxa11, HoxB13 and T-Brachyury, and regions distal to the TSS of Nanos3 and the first intron of Dppa3 (Fig. 5c,d and Supplementary Table S6) .
Analysis of functional categories of targets revealed highly significant binding to PGC genes (for example, Nanog, Dppa3 and Pou5f1), and E6.0 epiblast (for example, activin and FGF receptor genes Acvr1b, Fgfr1 and Fgfr2). This is consistent with AP2γ being involved in PGC specification from epiblast cells (Fig. 5e ,f and Supplementary  Table S6 ). Furthermore, AP2γ was enriched for genes involved in morphogenesis and development, indicating a relevance to PGCs and somatic gene repression.
Transcriptional network for PGC specification
Next, we combined all available information for a detailed scrutiny of how the key regulators induce PGCs. With respect to gene expression in PGCs versus soma at E7.5, AP2γ was significantly enriched on both induced and repressed genes (Fig. 6a) , as confirmed by the hyper-geometric distribution statistical test (Fig. 6b) . The repressed genes were also co-bound by BLIMP1-AP2γ, and by PRDM14-AP2γ, and co-binding of all three factors showed enhanced enrichment with an increased degree of repression (Fig. 6a, left panel) , more so than with either PRDM14 or BLIMP1 alone. In contrast, the induced genes were preferentially enriched for PRDM14 and AP2γ together (Fig. 6a,b right panels) , where the enrichment of BLIMP1 alone or in combinations was statistically not significant ( BLIMP1, AP2γ and PRDM14 co-binding on repressed genes included developmental and signalling genes, particularly those of Fgf and Wnt signalling. BLIMP1 was preferentially bound to proliferation genes, and PRDM14 and AP2γ to cell-motility and cytoskeleton organization genes (Supplementary Figs S5a and S6a), indicating initiation of PGC migration. All three factors are over-represented on induced genes involved in actin cytoskeleton organization and intracellular signalling cascades (Supplementary Figs S5b,S6b) , although PRDM14, either alone or with AP2γ, is predominant over BLIMP1. Critically, PRDM14 binds to PGC-specific genes, including Tcfap2c (encoding AP2γ), Sox2 and Kit as well as Dnd1, Nanos3, Dppa3, Prdm1 (encoding BLIMP1) and Prdm14 (Fig. 6e and Supplementary  Fig. S6 ). Furthermore, AP2γ binds to Dppa3 as well as Nanos3, and acts cooperatively with PRDM14 in the induction of Nanos3 (Figs 1c, 6e and Supplementary Fig. S6 ). All three factors are involved in the induction of Dnd1 (Fig. 1c) . Thus, after the induction of AP2γ by BLIMP1, it cooperates with PRDM14 to induce PGC genes.
In the context of a compendium of transcription factors in mESCs (ref. 42 ), BLIMP1 clustered predominantly with self-renewal and polycomb factors, consistent with somatic gene repression ( Fig. 7 and Supplementary Fig. S7 ). PRDM14 clustered with pluripotency transcription factors, but AP2γ associated weakly with factors in the compendium (Supplementary Fig. S7 ). This underlines the context-dependent combinatorial action of these three factors, which as expected is not fully captured in comparison with mESCs factors.
A key role of the transcriptional network is in initiating epigenetic reprogramming in PGCs. Consistently, BLIMP1 and PRDM14 repress Kdm6b encoding a H3K27 demethylase, whereas PRDM14 mediates the induction of the H3K9 demethylase Kdm4b, and together with BLIMP1, induces Kdm3a ( Supplementary Fig. S5a,b) . This ensures the erasure of H3K9me2 that is a prerequisite for global DNA demethylation 43 . The two factors also repress the de novo DNA methyltransferase Dnmt3b as well as Uhrf1, encoding an accessory protein for the maintenance DNA methyltransferase DNMT1; this facilitates global DNA demethylation in PGCs (Supplementary Fig. S6a ). BLIMP1 and PRDM14 each bind to one of the two promoters to repress Uhrf1 in PGCs (Fig. 6e) , whereas PRDM14 alone in mESCs is insufficient to do so 44 . The regulation of histone and DNA methylases links PGC specification to the dynamic and genome-wide epigenetic reprogramming 45 . BLIMP1 and PRDM14 bind extensively to differentially expressed genes during PGC specification, whereas AP2γ binds to a subset of them and perhaps acts as a facilitator of key events, except perhaps for chromatin modifications.
The proposed transcriptional network is interdependent, because Tcfap2c (encoding AP2γ) expression is dependent on BLIMP1. Expression of Prdm14 and Prdm1 (encoding BLIMP1) expression is mutually interdependent as revealed by genetic experiments 6, 7 . PRDM14 also binds Tcfap2c and could enhance Tcfap2c expression after its induction by BLIMP1. This supports an obligatory functional relationship between BLIMP1, PRDM14 and AP2γ as critical regulators of PGC specification.
Direct induction of PGC-like fate by BLIMP1, AP2γ and PRDM14 in vitro
Next we investigated whether BLIMP1, AP2γ and PRDM14 are sufficient to directly induce PGC fate and used the in vitro induction of PGCLCs to test this premise 28 . PGCLCs can be induced in response to cytokines (Fig. 8a, left panel) , which we observed in 47.4-52.6% of the cells after 4 days. Using the same reporter cells harbouring doxycycline-inducible constructs for the three transcription factors, we observed induction of PGCLCs in the absence of cytokines in ∼45-60% of the cells (Fig. 8a, right panel) . Both the overall response and transcriptional analysis by qPCR using the sorted fluorescent PGCLCs were remarkably similar to those induced by cytokines with respect to the key PGC, epigenetic and somatic cell regulators. The response to the transcription factors was slightly enhanced (Fig. 8b and Supplementary Fig. S8c ), as reflected in the higher induction of Dppa3 and Nanos3, and a more pronounced repression of HoxB1 and T-Brachyury. This observation establishes the principle that the proposed transcriptional network delineating specific and combined functions of BLIMP1, AP2γ and PRDM14 accounts for the necessary gene expression changes for PGC specification. Further work in the future will advance our knowledge of how these factors, both individually and in combination, induce PGC fate.
DISCUSSION
We present a comprehensive examination of the initiation of PGC specification by the combinatorial roles of BLIMP1, AP2γ and PRDM14, leading to a unique epigenetic program culminating in the epigenetic basal state 45, 46 . Co-expression of the three factors is by itself apparently sufficient to induce PGC-like fate in the absence of cytokines, and supports the proposed tripartite genetic network for PGC specification.
BLIMP1, PRDM14 and AP2γ contribute to the repression of mesodermal genes in PGCs to set them apart from their somatic neighbours; until then, these cells are indistinguishable from each other. BLIMP1 has a dominant function in this respect, which is reinforced by PRDM14 and AP2γ. In contrast, PRDM14 and AP2γ together are associated with gene induction. Notably, Tcfapc2 (encoding AP2γ) is a direct target of BLIMP1 and induced by it in P19EC cells in vitro, and probably maintained thereafter by PRDM14 in PGCs. Tcfap2c fails to be induced in BLIMP1 mutant PGC-like cells in vivo and its induction by BLIMP1 is perhaps the vital link for the initiation of the PGC-specific genes.
The high overlap of AP2γ targets with those of BLIMP1 and PRDM14 implies that it cooperates, augments or otherwise modulates the response of a subset of the targets. Furthermore, the distinct and predominant binding of BLIMP1 to promoter regions as opposed to the binding to gene-distal regulatory regions noted for PRDM14 (ref. 47 ) suggests parallel mechanisms in regulating transcription. The collaborative role of AP2γ is also reflected in its broad distribution that is centred on promoters, but potentially, encompasses distal elements.
This comprehensive insight into PGC specification in mice may facilitate investigations on germ cells in other mammals, including humans, and enhance an understanding of context-dependent functions of transcription factors. For example, AP2γ has a role in trophectoderm differentiation in conjunction with CDX2 and EOMES, whereas it participates in the repression of Eomes in PGCs. BLIMP1 also drives cell fate commitment in several different lineages, whereas PRDM14 is crucial for pluripotency in ESCs [47] [48] [49] . These differences are presumably linked to the molecular control of competence, which precedes and anticipates specific cell fate decisions.
A fundamental property of early germ cells are the unique epigenetic changes that ensue following PGC specification, leading to global erasure of DNA methylation and acquisition of a basal epigenetic state.
The mechanism that regulates this unique resetting of the epigenome in germ cells could in principle be extended towards approaches for modifying epigenetic states of normal and diseased tissues. This study may help towards achieving wider objects of general interest in the field of regenerative medicine.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
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Plasmids. The cDNA encoding BLIMP1 was cloned into the multiple cloning site of pTRE-Tight from Promega. The tetracycline transactivator tTA cDNA, a kind gift from S. Jackson (Gurdon Institute, University of Cambridge, UK), was cloned into pCAC-IP. The PRDM14 and AP2γ expression constructs were described previously 50 . For inducible expression of BLIMP1, AP2γ and PRDM14, the cDNAs were cloned into a piggy-bac vector downstream of a tetracycline response element (TRE). The vectors were co-transfected with a piggy-bac vector containing the reverse tetracycline transactivator rtTA, as well as a vector transiently expressing piggy-bac transposase.
Cells. The mouse P19ECs were obtained from ATCC and were cultured in DMEM, 10% fetal calf serum, 2 mM l-glutamine (Gibco) and 50 µg ml −1 penecillin/streptomycin (Gibco). P19ECs stably expressing PRDM14 and AP2γ were generated as previously described 1 . Lipofectamine 2000 (Invitrogen) was used for transfections. PGCLCs were cultured as previously described 36 , from Oct4 Distal Enhancer EGFP reporter ESCs (GOF), and collected on day 3 after PGCLC induction for ChIP, and on days 2 and 4 for RT-qPCR after flow cytometric sorting for EGFP.
ChIP-seq. Nuclear extracts from P19ECs co-transfected with TRE-Tight BLIMP1-EGFP, and pCAG-tTA-IP for BLIMP1, were subjected to ChIP, using previously described methods 51 . A mouse anti-GFP (3E6) from Invitrogen was used (A11120). The same protocol was used for AP2γ, with a rabbit polyclonal from Santa Cruz (H-77). A total of 10 µg of antibody was used per immunoprecipitation for both antibodies above. Library preparation of the BLIMP1 ChIP was performed using Illumina ChIP-seq DNA Sample Preparation Kit (cat. No 1003473). The AP2γ ChIP-seq libraries were generated using the Nugene Ovation Ultralow Library Kit. Sequencing was performed on an Illumina Genome Analyser for the BLIMP1 ChIP, and an Illumina HiSeq 2000 sequencer for AP2γ, at the Cambridge Research Institute Genomics Facility, generating single end 36 bp reads. The data were deposited in the Array Express repository http://www.ebi.ac.uk/arrayexpress. For validation of BLIMP1 ChIP-seq results in PGCLCs, 5 × 10 6 cells from unsorted cultures with approximately 60% induction of PGCLCs were used for ChIP with a polyclonal antiserum against BLIMP1 (CLU267; ref. 35 ) or a corresponding pre-immune serum; the sera were used at a 1:100 dilution. The resulting immunoprecipitated DNA was processed as described before 52 and qPCR was performed for target regions.
ChIP-seq analysis. Sequences corresponding to adaptors were removed from the sequence library, and the sequence tags subsequently mapped to the mouse genome (NCBI Mouse v37/mm9) using BWA (ref. 53 ). The BWA outputs were filtered for only unique hits and no more than 33 of the same base per read. Sequences mapping to the BLIMP1 ORF (chr 10:44, 156, 983-44, 178, 554) were removed from the BLIMP1 ChIP-seq data. Peaks were called for the BLIMP1 ChIP-seq with CisGenome 54 , at FDR ≤ 0.001 and MACS (ref. 55) using a P-value cutoff of 1×10 −9 . Peak regions for each individual experiment were then intersected using BED tools 56 to only include peak regions identified by both algorithms. Subsequently the peak regions for the two experiments were intersected again to include only reproducible sites of binding in the final list of high-confidence peaks. For the AP2γ ChIP-seq, peaks were called using MACS using a P-value cutoff of 1 × 10 −250 , tag count of 50 tags and fold change of ×20 to generate a list of high-confidence peaks. For assessing the distance of peaks to gene TSSs the ChIPpeakAnno package from Bioconductor was employed 57 . Peaks were assigned to genes using a cutoff distance of 10 kb upstream and 2 kb downstream of genes, for functional category enrichment analysis of genes associated with peaks and the gene list analysed with Panther 58 . Validation of new high-confidence peak regions was done in duplicate experiments using either EGFP-and BLIMP1-EGFP-transfected cells or triplicate experiments with AP2γ stables for subsequent ChIP-qPCR analysis. For the validation ChIP experiments, 10 µg total of the antibodies listed above was used.
Sequence motif analysis.
De novo motif discovery was performed using MEME-ChIP (http://meme.sdsc.edu/meme/cgi-bin/meme-chip.cgi; ref. 59). For TRANSFAC motif scanning, we used the web-based tool Centdist 57 . The mouse genome was scanned for the AP2γ motif using the HOMER (http://biowhat.ucsd. edu/homer/) software package's ScanMotifGenomeWide.pl function with default parameters 61 .
Microarray analysis. At 24 and 48 h post transfection, cells were dissociated from the culture plates and subjected to flow cytometric analysis and sorting using a MoFlo high-speed cell sorter (Dako Cytomation). At 24 h, 2.5-5 × 10 5 fluorescent cells were collected from each of 2 gates designated as high (HI) and low (LO). At 48 h, cells were collected from as inglegate of cells. The cells were suspended in Trizol (Invitrogen), total RNA isolated and cleaned up with Qiagen RNeasy microkit. The samples were analysed on a Bioanalyzer (Agilent Technologies) before amplification and cRNA generation for hybridization onto Illumina Mouse WG-6v2.0 Expression BeadChip microarrays. cRNA generation, quality control and hybridization were performed by Cambridge Genomic Services at the University of Cambridge. The experiment and subsequent hybridizations were performed in triplicate, and microarray data were deposited in the ArrayExpress repository. Statistical analysis was performed as previously described 50 , with the exception that differential expression between groups of two or more profiles was assessed using the output of a moderated t -test for each probe set. Differential expression was deemed significant at an FDR of 0.005.
ChIP-bound regions, identified by ChIP-seq experiments, were assigned to microarray probe sets as follows. Transcripts and their genomic coordinates were related to probe sets using the Bioconductor:biomaRt interface to the Ensembl 60 database (http://www.ensembl.org/). The Bioconductor:IRanges package was employed to identify ChIP-bound regions that occurred within −10 kb upstream and +2 kb downstream of each transcript.
The over-representation of functional categories of differentially expressed genes was assessed using the online tool DAVID (ref. 62).
qPCR. qPCR reactions were performed with SybrGreen JumpStart Taq ReadyMix (Sigma) using 0.2 µM of gene specific forward and reverse primers (see Table S7 for primer sequences). In the case of cDNA, 5 ng of template was used per reaction. Quantification was performed as previously described 50 . Mean threshold cycles were determined from two technical replicates unless otherwise stated using the comparative Ct method. RT-qPCR expression levels were normalized to Ppia.
RNA-seq. E6.5 and E7.5 PGCs were originally selected as BLIMP1-EGFP-positive cells, the E7.5 somatic cells were BLIMP1-EGFP negative and the E8.5 PGCs expressed Oct4-EGFP. The BLIMP1 −/− PGCs were picked at random from dissected embryos for downstream selection of PGC-like cells. Two cells were selected from each time point according to the expression of somatic or PGC markers. The PCGs selected were positive for the expression of the lineage markers Prdm1 (apart from Prdm1 mutant PGCs) and Dppa3, but negative for the early mesodermal marker HoxB1. The E7.5 somatic cells selected were negative for the above PGC lineage markers but HoxB1 positive. The cDNA of the selected cells was amplified and sequenced using high-throughput sequencing (RNA-seq) as previously published 63 . Reads were aligned to the mouse genome (mm 9) using the Bowtiesoftware, and all reads that mapped at more than 10 genomic locations allowing one mismatch were discarded. Reads were mapped to the extracted genomic sequences allowing one mismatch, and subsequently to known splice junctions (±42 nt) allowing no more than three mismatches. Read counts were normalized using the TMM method and differential expression analysis was performed using the edgeR Bioconductor package. The data were deposited in the ArrayExpress repository (http://www.ebi.ac.uk/arrayexpress).
For hierarchical clustering of the expression profiles, 6,838 genes with higher variability in expression (interquantile range >2.5) were selected, and time points clustered on the basis of the Euclidean distance of normalized expression values between genes using complete linkage clustering with Cluster3 software 64 http://bonsai.hgc.jp/ ∼ mdehoon/software/cluster/software.htm). The correlation of different expression profile comparisons, between the RNA-seq time points as well as microarray analysis was performed by selecting the 10% most highly induced or repressed genes and calculating the pair-wise Pearson correlation coefficients.
Transcription factor association scores and enrichment analysis. ChIP-seq data sets were aligned using Bowtie and peaks were called with MACS. Transcription factor association scores were calculated on the basis of the MACS-generated coverage profiles per genomic coordinates. For each gene i the transcription factor association scores of BLIMP1 were calculated as described previously 65 ; sum (g k ) * e(−d/d0), where g k is the RPM-normalized intensity; that is, the number of reads aligned to the coordinate k per million reads in the ChIP-seq data set, d k is the distance (number of nucleotides) between the TSS of gene i and the coordinate k, and d k is a constant (500 bp). These sums were generated up to ±100 kb. When calculating the transcription factor target enrichment on sets of differentially expressed genes the enrichment of high-confidence peaks, the number N 1 of BLIMP1, PRDM14 or AP2γ peaks in the set of N differentially expressed genes (log 2 FC <X ; log 2 (FC) > X ), was compared with the average number of peaks in the whole data set for each factor. Target enrichment is given as log2[(N 1 /N )/(B/A)], where B is the total number of peaks and A is the total number or genes in the RNA-seq expression data set. In analogy, the average BLIMP1 TF score in the set of N differentially expressed genes was compared to the average total BLIMP1 TF score. For the P19EC intersection enrichment the set of N differentially expressed genes in E7.5 PGCs versus E7.5 Soma (log2FC < X ,log2(FC) > X ; P value <0.01) was intersected by genes differentially expressed (logFC < −0.3 (10% quantile), logFC > 0.38 (90% quantile); P value <0.01), after BLIMP1 transfection to P19ECs.
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M E T H O D S
Transcription network analysis. Genes repressed and induced in E7.5 PGCs versus E7.5 soma were classified into categories based on whether they were bound by BLIMP1, PRDM14 or both, and whether there were AP2γ motifs present in the binding regions or whether they were bound by AP2γ. Subsequently, GO-analysis of genes in each category was performed and the GO-term profiles, consisting of the gene count for each term with 4 genes or more in at least one of the binding categories, were clustered using Cluster 3. We used Cytoscape to construct network binding profiles of the induced and repressed genes belonging to over-represented GO-term categories 66 . To assess the statistical significance of overlap between genomic binding sites of the three factors, 10,000 random permutation trials were performed where in each trial, BLIMP1, AP2γ and PRDM14 peak regions were randomly re-assigned and complete peak regions overlapping by 1 bp or more between pairs were counted.
Accession numbers. The primary accession numbers are E-MTAB-1600 for the AP2γ ChIP-seq data, E-MTAB-1599 for the BLIMP1 ChIP-seq data, E-MTAB-865 for the microarray data and E-MTAB-1178 for the RNA-seq data. The referenced accession numbers are GSE25409 for the PRDM14 ChIP-seq, GSE24841 for the SIN3a ChIP-seq, GSE20530 for the NELFA ChIP-seq, GSE26680 for the RING1B ChIP-seq and GSE13084 for EZH2 ChIP-seq. and somatic neighbours (E7.5 soma) as well as Blimp1 null PGC-like cells (E7.5 Blimp1KO), assayed by single cell RNAseq. The first column shows the RefSeqID, the second column the gene symbol, the third column shows the gene localization and strand. The values indicate the expression levels in log 2 (reads pr. million). 
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